Advertisement
Proton pump inhibitors at higher doses are associated with an increased risk of ischemic stroke

AHA: Proton Pump Inhibitors Tied to Ischemic Stroke Risk

0
Researchers concerned about high doses of meds like esomeprazole and omeprazole
Among a nationally representative cohort of commercially insured patients there was a small increase in the rate of cardiac stress testing from 2005 to 2012

AHA: Small Increase in Cardiac Stress Testing 2005 to 2012

0
Findings among nationally representative cohort of commercially insured patients aged 25 to 64 years
Nearly one-third of Americans newly diagnosed with atrial fibrillation don't realize the condition puts them at increased risk for stroke

AHA: Knowledge of Stroke Risk Lacking Among A-Fib Patients

0
Study finds gaps in what patients know about atrial fibrillation
Half of patients hospitalized with atrial fibrillation aren't receiving oral anticoagulants

AHA: Many A-Fib Patients Not Receiving Oral Anticoagulants

0
Only 46 percent of patients with indications received OACs at discharge from hospital
Sustained clinical benefit has been observed in patients with heart failure with preserved left ventricular ejection fraction treated with an interatrial septal shunt device that allows shunting to reduce the left atrial pressure

AHA: Interatrial Shunt Effective at One Year in Heart Failure

0
Findings for patients with heart failure with preserved left ventricular ejection fraction
Exercising during and after cancer treatment is safe and improves quality of life

Cancer Patients Benefit From Exercise During, After Treatment

0
Studies show better physical function, quality of life for those who did strength training, aerobic activity
Bisphosphonates reduce the risk of vertebral

Findings Support Bisphosphonate Use in Men With Osteoporosis

0
Reduced risk seen for vertebral and possibly nonvertebral fractures
For patients with inflammatory joint diseases

ACR: High Demand for CVD-Preventive Meds in IJD

0
High indication for medications, but initiation is infrequent in inflammatory joint disease cohort
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events

GI Adverse Events Up With GLP-1 Receptor Agonists

0
Risk varies based on dose, background medications, and type of GLP-1 RA
In patients with acute cough

Only Slightly Worse Disease Course for Bacterial LRI

0
More often return for second consult than those without bacterial etiology in acute cough